ERG and prostate cancer: The 9FY monoclonal antibody was found to be highly specific in the detection of ERG protein in cell culture-based experiments and human prostate cancer specimens by immunofluorescence and immunohistochemistry (IHC), respectively, without cross-reactivity to other members of the ETS family [18,20].